Methods For Treating Hyperbilirubinemia With Stannsoporfin And Phototherapy
Number of patents in Portfolio can not be more than 2000
United States of America
Stats
-
N/A
Issued Date -
Jan 2, 2020
app pub date -
May 12, 2017
filing date -
May 12, 2017
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
Methods of treating hyperbilrubinemia or reducing total serum bilirubin levels include initiating phototherapy on an infant while substantially simultaneously administering to the infant a therapeutic amount of stannsoporfin. Various embodiments are directed to treating hyperbilirubinemia and decreasing bilirubin levels.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully